• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Genomics Market Size & Growth, 2027 | Industry Overview Report

Genomics Market Size & Forecast Report, 2016 - 2027

Report ID: MN17619474  |  Published: February 2020  |  No of Pages: 120
Format: Electronic (PDF)  |  Industry: Biotechnology  |  Publisher: Grand View Research

Synopsis:

Concerning the report issued by the specialists, the scope of the global Genomics Market was appraised at US$ 17.2 billion in 2019. It is estimated to increase by a CAGR of 7.7% during the period of forecast and touch US$ 31.1 billion by the completion of 2027.

The genome is the hereditary material of a creature. It comprises together the noncoding DNA and genes, along with chloroplast DNA and mitochondrial DNA. The learning of genomes is known as genomics. The genomics industry is attaining grip due to its uses in several areas of study for example intragenomic phenomenon comprising heterosis, epistasis, pleiotropy, and additional interactions amongst alleles and loci contained by the genome. In this age of medicinal and life science modernizations affecting itself such as an unavoidable acceptance for the sustainability of manhood, the research of genomic is composed for exponential development due to authoritative hereditary revolutions serving it.

Drivers:

The issues like the increasing finance by the government and development in the number of genomics projects, declining prices of sequencing, increasing areas of genomics application, and the admission of new-fangled companies in addition to start-ups in the field of genomics are motivating the development of the genomics market.

The capability of the medicinal community to utilize the existing genomic data in custom-made medicine is expected to considerably influence the genomics industry. Additionally, the dipping price tag of sequencing has permitted complete genome sequencing at a precise less price. Researchers are linking the sequencing-generated data with diagnostics. This has supported its usefulness in augmenting custom-made treatment backgrounds.

Restraints:

On the other hand, the greater prices of genomic apparatus may restrict the development of the market to a definite range during the period of approaching years.

Classification:

The global genomics market can be classified by End-Use, Deliverables, Application & Technology, and Region. By End Use, it can be classified as Clinical Research, Hospitals & Clinics, Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, and Other End-users. By Deliverables, it can be classified as Services, Products, System & Software, and Consumables. By Application & Technology, it can be classified as Epigenetics, Pathway Analysis, Biomarker Discovery, Functional Genomics, Purification & Nucleic acid extraction, Microarray, PCR (polymerase chain reaction), Sequencing, and Others.

Regional Lookout:

By Region, the global genomics industry can be classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America detained the biggest share of the general market. Obtainability of classy organization of healthcare, a growing asset for the activities of research by government administrations, and growing cognizance of the patient has headed to the augmented technical progressions within this market. Local Existence of important companies within the region, for example, Danaher Corporation, Illumina, Inc., Agilent Technologies, Affymetrix, Inc., Cepheid, Inc., GE Healthcare, and Bio-Rad Laboratories, Inc. can likewise be credited to the greater share of the market.

The Asia Pacific is likely to observe the speedy development during the period of approaching years. Emerging organization within these nations has headed to the augmented demand for biomarkers for diagnostics. Due to the growth in acceptance and consciousness regarding the number of genomics technologies the market is expected to propagate within the developing nation-state for example India and China for discovery, treatment, and prediction of several hereditary complaints about example cancer, diabetes, and others.

Several stimulating humanoid genome sequencing assignments are being carried out. One of the maximum latest projects is Genome Asia 100K (GA 100K). Beneath this project, 100,000 Asian genomes will be sequenced and examined. This will support fast-track population-specific medicinal developments and exactness in the medication.

Companies:

Some of the important companies for the genomics market are Myriad Genetics, Inc., 23& Me, Inc., Pacific Biosciences, F. Hoffmann-La Roche Ltd., Danaher, Agilent Technologies, Foundation Medicine, Inc., Oxford Nanopore Technologies, Illumina, Inc., BGI, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc.

Market Segment:

Genomics Deliverable Outlook (Revenue, USD Million, 2016 - 2027)
    • Products
        • Instruments & Software
        • Consumables & Reagents
    • Services
        • Core Genomics Services
        • NGS-based Services
        • Biomarker Translation Services
        • Computational Services
        • Others

Genomics Application & Technology Outlook (Revenue, USD Million, 2016 - 2027)
    • Functional Genomics
        • Transfection
        • Real-time PCR
        • RNA interference
        • Mutational analysis
        • SNP analysis
        • Microarray analysis
    • Epigenetics
        • Bisulfite sequencing
        • Chromatin immunoprecipitation-sequencing (ChIP & ChIP-Seq)
        • Methylated DNA immunoprecipitation (MeDIP)
        • High-resolution melt (HRM)
        • Chromatin accessibility assays
        • Microarray analysis
    • Pathway Analysis
        • Bead-based analysis
        • Microarray analysis
        • Real-time PCR
        • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
    • Biomarker Discovery
        • Mass spectrometry
        • Real-time PCR
        • Microarray analysis
        • Statistical analysis
        • Bioinformatics
        • DNA sequencing
    • Others

Genomics End-use Outlook (Revenue, USD Million, 2016 - 2027)
        • Clinical & Research Laboratories
        • Academic & Government Institutes
        • Hospitals & Clinics
        • Pharmaceutical & Biotechnology Companies
        • Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
    • the Asia Pacific
        • Japan
        • China
    • Latin America
        • Brazil
    • Middle East and Africa (MEA)
        • South Africa

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available